October 5, 2021 –
Portfolio Category: Prospects
FACIT-37 | Dalriada Therapeutics
October 5, 2021 –
FACIT-55 | University of Toronto (mitochondrial RNA polymerase inhibitor, Dr. R. Laposa)
FACIT-38 | KA Imaging
October 5, 2021 –
FACIT-57 | Air Microfluidic Systems Inc.
October 5, 2021 –
FACIT-39 | Radialis Medical
October 5, 2021 –
FACIT-58 | Tenomix
October 5, 2021 –
FACIT-21 | Capnostics (acquired by PAVmed)
October 5, 2021 –